Clinical Trial

Dachengqi Decoction for Enhancing Early Gastrointestinal Recovery After Whipple Surgery

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2025 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To investigate the clinical efficacy of the traditional Chinese medicine formula Dachengqi Decoction in promoting early gastrointestinal function recovery after Whipple surgery, and to evaluate its impact on postoperative nutritional status, hospitalization duration, and complication rates, thereby providing evidence for optimizing postoperative rehabilitation strategies in pancreaticoduodenectomy patients.
Trial Details
NCT Number NCT06948474
Lead Sponsor China-Japan Friendship Hospital
Conditions Whipple Operation
Enrollment 45 participants
Start Date 2024-08-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-29